• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Mitogen-activated protein kinase kinase kinase 14 (MAP3K14), Truncated

The pipeline for the recombinant Human MAP3K14 protein production in e.coli cells consists of the following consecutive steps: construction of the expression vector encoding the Human MAP3K14 protein (400-655aa), its transformation into e.coli cells, high-density cultivation and induction of the positive cells, cell lysis, and expression analysis. The protein features a N-terminal 10xHis tag and C-terminal Myc tag fusion. The resulting recombinant Human MAP3K14 protein is purified from the cell lysate through affinity purification, and its purity is greater than 85% determined by the SDS-PAGE.

ACP01815

The pipeline for the recombinant Human MAP3K14 protein production in e.coli cells consists of the following consecutive steps: construction of the expression vector encoding the Human MAP3K14 protein (400-655aa), its transformation into e.coli cells, high-density cultivation and induction of the positive cells, cell lysis, and expression analysis. The protein features a N-terminal 10xHis tag and C-terminal Myc tag fusion. The resulting recombinant Human MAP3K14 protein is purified from the cell lysate through affinity purification, and its purity is greater than 85% determined by the SDS-PAGE.

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP01815 Target NameMAP3K14
Target SynonymsSerine/threonine-protein kinase NIK NF-kappa-beta-inducing kinaseFormLiquid or Lyophilized powder
Expression SystemE.coliExpression Range400-655aa
Mol Weight35.4 kDaProtein LengthPartial
PurityGreater than 85% as determined by SDS-PAGE.Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ99558
Background Information
  • Uniprot Id

    Q99558

  • Target Species

    Human

  • Target Name

    MAP3K14

  • Target Full Name

    Mitogen-activated protein kinase kinase kinase 14

  • Target Function

    Lymphotoxin beta-activated kinase which seems to be exclusively involved in the activation of NF-kappa-B and its transcriptional activity. Promotes proteolytic processing of NFKB2/P100, which leads to activation of NF-kappa-B via the non-canonical pathway. Could act in a receptor-selective manner.

  • Target Subcellular Location

    Cytoplasm.

  • Target Protein Families

    Protein kinase superfamily, STE Ser/Thr protein kinase family, MAP kinase kinase kinase subfamily

  • Target Tissue Specificity

    Weakly expressed in testis, small intestine, spleen, thymus, peripheral blood leukocytes, prostate, ovary and colon.

  • Target Research Area

    Biochemicals

  • Target Synonyms

    MAP3K14; FTDCR1B; HS; HsNIK; M3K14_HUMAN; Map3k14; Mitogen activated protein kinase kinase kinase 14; Mitogen-activated protein kinase kinase kinase 14; NF kappa beta inducing kinase; NF-kappa-beta-inducing kinase; NIK; Serine/threonine-protein kinase NIK

  • Target Background

    This gene encodes mitogen-activated protein kinase kinase kinase 14, which is a serine/threonine protein-kinase. This kinase binds to TRAF2 and stimulates NF-kappaB activity. It shares sequence similarity with several other MAPKK kinases. It participates in an NF-kappaB-inducing signalling cascade common to receptors of the tumour-necrosis/nerve-growth factor (TNF/NGF) family and to the interleukin-1 type-I receptor.

Inquire Recombinant Human Mitogen-activated protein kinase kinase kinase 14 (MAP3K14), Truncated Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification